A dysregulation in CES1, APOE and other lipid metabolism-related genes is associated to cardiovascular risk factors linked to obesity

Obesity Facts

Volumn 3, Issue 5, 2010, Pages 312-318

  Marrades, M Pilar ^a   González Muniesa, Pedro ^a   Martínez, J Alfredo ^a   Moreno Aliaga, María J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

APOE; CES1; High fat diet; Lipid metabolism; Metabolic syndrome; Obesity

Indexed keywords

APOLIPOPROTEIN E; CARBOXYLESTERASE; CARBOXYLESTERASE 1; CYCLIC AMP DEPENDENT PROTEIN KINASE 2; CYCLIC AMP DEPENDENT PROTEIN KINASE 2 BETA; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HUMAN; LIPID DIET; LIPID METABOLISM; MICROARRAY ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION;

ABDOMINAL FAT; ADULT; APOLIPOPROTEINS E; CARBOXYLIC ESTER HYDROLASES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; SPAIN; YOUNG ADULT;

EID: 78049421380     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000321451     Document Type: Article

References (53)

1. Watt MJ, Spriet LL: Triacylglycerol lipases and metabolic control: implications for health and disease. Am J Physiol 2010;299:E162-168.
2. Westphal SA: Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008;9:23-29; discussion 30-21.
3. Oral EA, Chan JL: Rationale for leptin-replacement therapy for severe lipodystrophy. Endocr Pract 2010:16:324-333.
4. Frayn KN: Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002;45:1201-1210.
5. Laclaustra M, Corella D, Ordovas JM: Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis 2007;17:125-139.
6. Grundy SM: Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093-1100.
7. Lawson HA, Cheverud JM: Metabolic syndrome components in murine models. Endocr Metab Immune Disord Drug Targets 2010;10:25-40.
8. Marrades MP, Martinez JA, Moreno-Aliaga MJ: Differences in short-term metabolic responses to a lipid load in lean (resistant) vs obese (susceptible) young male subjects with habitual high-fat consumption. Eur J Clin Nutr 2007;61:166-174.
9. Martinez-Gonzalez MA, Lopez-Fontana C, Varo JJ, Sanchez-Villegas A, Martinez JA: Validation of the Spanish version of the physical activity questionnaire used in the nurses' health study and the health professionals' follow-up study. Public Health Nutr 2005;8:920-927.
10. World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-926.
11. Marrades MP, Milagro FI, Martinez JA, Moreno- Aliaga MJ: Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun 2006;339: 785-789.
12. Martinez-Cruz LA, Rubio A, Martinez-Chantar ML, Labarga A, Barrio I, Podhorski A, Segura V, Sevilla Campo JL, Avila MA, Mato JM: Garban: Genomic analysis and rapid biological annotation of cDNA microarray and proteomic data. Bioinformatics 2003;19:2158-2160.
13. Segura V, Podhorski A, Guruceaga E, Sevilla JL, Corrales FJ, Rubio A: Garban II: an integrative framework for extracting biological information from proteomic and genomic data. Proteomics 2006;6(suppl 1):S12-15.
14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, And Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association For The Study Of Obesity. Circulation 2009; 120:1640-1645.
15. Manolopoulos KN, Karpe F, Frayn KN: Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010;34:949-959.
16. Alibegovic AC, Hojbjerre L, Sonne M, Hall GV, Alsted TJ, Kiens B, Stallknecht B, Dela F, Vaag A: Increased rate of whole body lipolysis before and after nine days of bed rest in healthy young men born with low birth weight. Am J Physiol Endocrinol Metab 2010;298:E555-564.
17. Ishikawa K, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y: Subcutaneous fat modulates insulin sensitivity in mice by regulating TNF-alpha expression in visceral fat. Horm Metab Res 2006;38: 631-638.
18. Newhall KJ, Cummings DE, Nolan MA, McKnight GS: Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse. Mol Endocrinol (Baltimore) 2005;19:982-991.
19. Planas JV, Cummings DE, Idzerda RL, McKnight GS: Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J Biol Chem 1999;274:36281-36287.
20. Carnegie GK, Smith FD, McConnachie G, Langeberg LK, Scott JD: AKAP-lbc nucleates a protein kinase D activation scaffold. Mol Cell 2004;15:889-899.
21. Bridges D, MacDonald JA, Wadzinski B, Moorhead GBG: Identification and characterization of D-AKAP1 as a major adipocyte PKA and PP1 binding protein. Biochem Biophys Res Commun 2006;346:351-357.
22. Margareto J, Aguado M, Oses-Prieto JA, Rivero I, Monge A, Aldana I, Marti A, Martinez JA: A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model. Life Sci 2000;68:99-107.
23. Gomez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, Fruhbeck G: Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004;18:215-217.
24. Large V, Peroni O, Letexier D, Ray H, Beylot M: Metabolism of lipids in human white adipocyte. Diabetes Metab 2004;30:294-309.
25. Jocken JWE, Langin D, Smit E, Saris WHM, Valle C, Hul GB, Holm C, Arner P, Blaak EE: Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) protein expression is decreased in the obese insulin resistant state. J Clin Endocrinol Metab 2007;92:2292-2299..
26. Viguerie N, Vidal H, Arner P, Holst C, Verdich C, Avizou S, Astrup A, Saris WH, Macdonald IA, Klimcakova E, Clement K, Martinez A, Hoffstedt J, Sorensen TI, Langin D: Adipose tissue gene expression in obese subjects during low-fat and highfat hypocaloric diets. Diabetologia 2005;48:123-131. (Pubitemid 40174664)
27. Langin D, Arner P: Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol Metabolism 2006;17:314-320.
28. Nordstrom EA, Ryden M, Backlund EC, Dahlman I, Kaaman M, Blomqvist L, Cannon B, Nedergaard J, Arner P: A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-{ alpha})-like effector a (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005;54:1726-1734.
29. Soni KG, Lehner R, Metalnikov P, O'Donnell P, Semache M, Gao W, Ashman K, Pshezhetsky AV, Mitchell GA: Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem 2004;279: 40683-40689.
30. Steinberg GR, Kemp BE, Watt MJ: Adipocyte triglyceride lipase expression in human obesity. Am J Physiol 2007;293:E958-964.
31. Jernas M, Olsson B, Arner P, Jacobson P, Sjostrom L, Walley A, Froguel P, McTernan PG, Hoffstedt J, Carlsson LM: Regulation of carboxylesterase 1 (CES1) in human adipose tissue. Biochem Biophys Res Commun 2009;383:63-67.
32. Okazaki H, Igarashi M, Nishi M, Tajima M, Sekiya M, Okazaki S, Yahagi N, Ohashi K, Tsukamoto K, Amemiya-Kudo M, Matsuzaka T, Shimano H, Yamada N, Aoki J, Morikawa R, Takanezawa Y, Arai H, Nagai R, Kadowaki T, Osuga J-I, Ishibashi S: Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis. Diabetes 2006; 55:2091-2097.
33. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
34. Gruson E, Montaye M, Kee F, Wagner A, Bingham A, Ruidavets JB, Haas B, Evans A, Ferrieres J, Ducimetiere PP, Amouyel P, Dallongeville J: Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: The prime study. Heart (British Cardiac Society) 2010;96:136-140.
35. Le Lay S, Krief S, Farnier C, Lefrere I, Le Liepvre X, Bazin R, Ferre P, Dugail I: Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 2001;276:16904-16910.
36. Le Lay S, Ferre P, Dugail I: Adipocyte cholesterol balance in obesity. Biochem Soc Trans 2004;32: 103-106.
37. Buchmann J, Meyer C, Neschen S, Augustin R, Schmolz K, Kluge R, Al-Hasani H, Jurgens H, Eulenberg K, Wehr R, Dohrmann C, Joost H-G, Schurmann A: Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. Endocrinology 2007;148:1561-1573.
38. Huang ZH, Luque RM, Kineman RD, Mazzone T: Nutritional regulation of adipose tissue apolipoprotein e expression. Am J Physiol 2007;293:E203-209.
39. Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, Ishibashi S, Oka Y: Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 2007;56:24-33.
40. Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N: Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int J Obes 2008;32:1595-1605.
41. Greenow K, Pearce NJ, Ramji DP: The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berlin) 2005;83:329-342.
42. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-1607.
43. Annuzzi G, Giacco R, Patti L, Di Marino L, De Natale C, Costabile G, Marra M, Santangelo C, Masella R, Rivellese AA: Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Nutr Metab Cardiovasc Dis 2008;18:531-538.
44. Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD: Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes 2008;57:1482-1490.
45. Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ: Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 2002;277:10037-10043.
46. Voshol PJ, Rensen PC, van Dijk KW, Romijn JA, Havekes LM: Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models. Biochim Biophys Acta 2009;1791:479-485.
47. Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, Jong MC: Protection from obesity in mice lacking the VLDL receptor. Arterioscler, Thromb Vascular Biol 2001;21: 1488-1493.
48. Tacken PJ, Hofker MH, Havekes LM, van Dijk KW: Living up to a name: the role of the VLDL receptor in lipid metabolism. Curr Opin Lipidol 2001;12:275-279.
49. Zechner R, Moser R, Newman TC, Fried SK, Breslow JL: Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem 1991;266:10583-10588.
50. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR: Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007;56:16-23.
51. Kim Y, Park T: DNA microarrays to define and search for genes associated with obesity. Biotechnol J 2010;5:99-112.
52. MacLaren RE, Cui W, Lu H, Simard S, Cianflone K: Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics 2010;3:3. doi: 10.1186/1755-8794-3-3.
53. Li J, Yu X, Pan W, Unger RH: Gene expression profile of rat adipose tissue at the onset of high-fatdiet obesity. Am J Physiol 2002;282:E1334-1341.